This reveals three major molecular features delineating the diversity of clinical outcomes in chondrosarcomas: a high mitotic state, regional 14q32 loss of expression and IDH mutations leading to genome-wide DNA hypermethylation. This evidence concerns the gene IDH1 and chondrosarcoma.